Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.
Serum
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.
Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone. J Neurooncol. 2017 Dec; 135(3):581-591.
View in:
PubMed
subject areas
Adolescent
Adult
Antineoplastic Agents, Immunological
Bevacizumab
Brain Neoplasms
Disease Progression
Female
Follow-Up Studies
Glioma
Humans
Male
Middle Aged
Neoplasm Grading
Neoplasm Recurrence, Local
Propensity Score
Proportional Hazards Models
Re-Irradiation
Salvage Therapy
Time Factors
Treatment Outcome
Young Adult
authors with profiles
Ian F Dunn